Bibliographic Details
| Title: |
Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2 |
| Authors: |
Shashidhar Jaggaiahgari, Apoorva Munigela, Sasikala Mitnala, Deepika Gujjarlapudi, Venu Simhadri, Nageshwar Reddy D |
| Source: |
Vaccines, Vol 10, Iss 12, p 2146 (2022) |
| Publisher Information: |
MDPI AG, 2022. |
| Publication Year: |
2022 |
| Collection: |
LCC:Medicine |
| Subject Terms: |
SARS-CoV-2, COVID-19 vaccination, booster dose, Corbevax, Covishield, antibody response, Medicine |
| More Details: |
Despite effective vaccination programs, waning immunity in the vaccinated populations and the emergence of variants of concern posed a risk of breakthrough infections. A booster dose was demonstrated to provide substantially increased protection against symptomatic disease and hospitalization. We aimed to evaluate immune memory and the efficacy of reducing the rate of SARS-CoV-2 infection post heterologous booster with CORBEVAX after primary vaccination with two doses of COVISHIELD. SARS-CoV-2 S1/S2 spike IgG and RBD-specific antibody responses were elicited with both booster vaccines, with a greater response in individuals receiving heterologous booster. T and B memory responses were increased with booster dose, whereas B memory needed a longer duration to develop in individuals who received a homologous booster (90 days) in comparison to a heterologous booster (30 days). RBD-specific B memory and antibody-secreting (non-memory) B lymphocytes were enhanced with both boosters; however, the duration of response was longer with the heterologous booster compared to the homologous, indicating greater protection with the heterologous booster. The rate of infection 14 days after administration of the heterologous booster was comparatively lower than that of the homologous booster, with the symptoms being much less or asymptomatic. |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
2076-393X |
| Relation: |
https://www.mdpi.com/2076-393X/10/12/2146; https://doaj.org/toc/2076-393X |
| DOI: |
10.3390/vaccines10122146 |
| Access URL: |
https://doaj.org/article/9f12403052134e0ca4468532b6d69928 |
| Accession Number: |
edsdoj.9f12403052134e0ca4468532b6d69928 |
| Database: |
Directory of Open Access Journals |
